{
    "clinical_study": {
        "@rank": "10028", 
        "arm_group": [
            {
                "arm_group_label": "Psycho-social cognitive-behavioral therapy based training", 
                "arm_group_type": "Experimental", 
                "description": "Based on Ellgring et al.: Psychosoziales Training bei neurologischen Erkrankungen - Schwerpunkt Parkinson"
            }, 
            {
                "arm_group_label": "Unspecific group training", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Health Enhancement Program\nSee MacCoon et al. 2012:\nThe validation of an active control intervention for Mindfulness Based Stress Reduction (MBSR)"
            }
        ], 
        "brief_summary": {
            "textblock": "Patients with Parkinson's disease (PD) will be trained using a cognitive behavioral\n      group-training-program to reduce stress and augment quality of life. An unspecific  group\n      with the same amount and frequency of meetings is used as a control group. For the\n      evaluation of the training effects, scales to assess quality of life, analyses of\n      psychopathological variations as well as neurocognitive tests will be used."
        }, 
        "brief_title": "Training of Psychosocial Skills for Patients With Parkinson's Disease", 
        "condition": [
            "Parkinson's Disease", 
            "Mild Cognitive Impairment"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Parkinson Disease", 
                "Cognition Disorders"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with idiopathic Parkinson's disease according to United Kingdom Parkinson's\n             Disease Brain Bank Criteria, being either cognitively normal, suffering from Mild\n             Cognitive Impairment  or having mild dementia. Patients must be able to give their\n             written informed consent.\n\n        Exclusion Criteria:\n\n          -  Moderate or severe dementia (DMS-IV, MMS <24), other neurological or psychiatric\n             diseases of the brain not related to PD, secondary parkinsonism, physical impairment\n             hindering the adequate execution of the training, insufficient knowledge of German or\n             pregnancy are exclusion criteria. Deep Brain Stimulation (DBS) is no exclusion\n             criterion."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "95 Years", 
            "minimum_age": "45 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 23, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02048605", 
            "org_study_id": "BSLTraining2"
        }, 
        "intervention": [
            {
                "arm_group_label": "Psycho-social cognitive-behavioral therapy based training", 
                "intervention_name": "Psycho-social CBT based training", 
                "intervention_type": "Behavioral", 
                "other_name": [
                    "According to Ellgring et al. :", 
                    "Psychosoziales Training bei neurologischen Erkrankungen - Schwerpunkt Parkinson"
                ]
            }, 
            {
                "arm_group_label": "Unspecific group training", 
                "intervention_name": "Unspecific group training", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 20, 2014", 
        "link": {
            "url": "http://parkinson-team.ch/"
        }, 
        "location": {
            "contact": {
                "email": "Peter.Fuhr@usb.ch", 
                "last_name": "Peter Fuhr, Prof.", 
                "phone": "+412652525"
            }, 
            "facility": {
                "address": {
                    "city": "Basel", 
                    "country": "Switzerland", 
                    "zip": "4031"
                }, 
                "name": "University Hospital Basel"
            }, 
            "investigator": {
                "last_name": "Peter Fuhr, Prof.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "2", 
        "official_title": "Basel Training Study II: Training of Psychosocial Skills for Patients With Parkinson's Disease", 
        "other_outcome": {
            "description": "Questionnaire for measuring psychosocial problems, no official english translation available.", 
            "measure": "Belastungsfragebogen f\u00fcr Parkinson-Patienten (burden questionnaire)", 
            "safety_issue": "No", 
            "time_frame": "Before and after training, after 6 month"
        }, 
        "overall_contact": {
            "email": "Peter.Fuhr@usb.ch", 
            "last_name": "Peter Fuhr, Prof.", 
            "phone": "+41(0)61 265 25 25"
        }, 
        "overall_official": {
            "affiliation": "University Hospital, Basel, Switzerland", 
            "last_name": "Peter Fuhr, Prof. Dr. med.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Ethikkommission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Schedule for the Evaluation of Individual Quality of Life-Direct Weighting (SeiQol-DW)", 
            "safety_issue": "No", 
            "time_frame": "Before and after training, After 6-month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02048605"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital, Basel, Switzerland", 
            "investigator_full_name": "Peter Fuhr", 
            "investigator_title": "Prof. Dr. med.", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Alltagsbew\u00e4ltigungsskala (A-B-S) (Scale for the assessment of management of daily living)", 
            "safety_issue": "No", 
            "time_frame": "Before and after training, after 6 month"
        }, 
        "source": "University Hospital, Basel, Switzerland", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Parkinson Schweiz", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Bangerter-Rhyner Foundation", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "AbbVie", 
                    "agency_class": "Industry"
                }
            ], 
            "lead_sponsor": {
                "agency": "Peter Fuhr", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}